2024 ADC Insights and Trends

Out of the many bioconjugate strategies employed, ADCs have long been the most successful. After a ‘rocky’ patch in the mid-2010s with no new approvals, the ‘second wave’ of ADCs is well and truly on its way.​

This analysis reveals how this ‘second coming’ has benefitted from the difficult lessons learned and harsh realities faced by the ‘pioneering’ ADCs, such as reduced time in clinic and better molecule design to minimize toxicity. And acts as a reminder, of why continual learning is an excellent driver of innovation.

2024 ADC Insights and Trends Report

These insights and market knowledge have been developed based on the analysis and fusion of data collated from a variety of sources by the Beacon Consulting team.

  • Beacon ADC database: Vast repository of highly granular, current and historical data on ADCs including payloads; exploration by Beacon Consulting of its deepest recesses and use of smart interpretation facilitates in-depth understanding of trends and trajectories at quantitative scale, and over long time periods ​
  • External sources: Datapoints from additional external sources were used to complement existing Beacon data; clever inference and data fusion was used to increase the relevance and meaning of the outputs, enabling a higher quality of insights​
ADC insights and trends

You May Also Be Interested In…

Learn More About Consulting

What is Beacon Consulting?
  • We are specialist life sciences market research and consultants, delivering tailored insights across the full drug development and commercialisation lifecycle.
  • Combines scientific expertise, expert networks, and proprietary Beacon data to transform complex data into clear, strategic decisions.
  • Provides fully customised research, spanning qualitative interviews, quantitative analysis, and desk research, aligned to your specific business objectives.
  • Helps biopharma teams reduce risk, identify opportunities, and accelerate decision-making with actionable, decision-ready insights.
Learn More About Beacon Consulting

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search